Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Specialty Pharma: Tapping Japan

Jan 01 2007

Related Content

Bayer: Out of Trouble Come Opportunities

Oct 01 2004

The Rise of Regional Dealmaking

Sep 01 2006

Sosei's Drug Re-Profiling Strategy: A Three-Way Street

Dec 01 2003

European Players Wake Up to Japanese Opportunities

Apr 01 2004

Trade Sales Trump IPOs, Even for Platforms

Sep 01 2005

Related Companies

Astellas Pharma, Inc.

Daiichi Sankyo Co., Ltd.

FibroGen, Inc.

Asahi Kasei Corporation

Asahi Kasei Corporation

Acologix, Inc.

Toray Industries Inc.

MediciNova, Inc.

Nxera Pharma Co., Ltd.

Dyax Corp

Gyre Therapeutics, Inc.

Bayer AG

Aerovance, Inc.

IQVIA Holdings Inc.

Nipro Corporation

Meiji Seika Pharma Co., Ltd

Kyorin Pharmaceutical Co., Ltd.

Kissei Pharmaceutical Co., Ltd

Merck & Co., Inc.

Amgen, Inc.

Sanofi

Teva Pharmaceutical Industries Ltd.

Cephalon, Inc.

Novartis AG

Takeda Pharmaceutical Co. Ltd.

Affymax, Inc.

Additional Topics

Japan Asia Pacific Strategy Business Strategies Regulation BioPharmaceutical

More from Global Vision

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window